Pompe Program Update—FDA Approves Lumizyme
Posted on: May 27, 2010 - Filed under
On May 24, 2010 the FDA approved Genzyme’s Lumizyme for the treatment of patients with Pompe disease who are over 8 years of age and do not have evidence of cardiac hypertrophy.